From the Department of Emergency Medicine (T.E.M.), Alpert Medical School of Brown University, Providence, RI.
Center for Global Cardiometabolic Health, Brown University School of Public Health, Providence, RI (T.E.M., S.L.).
Hypertension. 2019 Oct;74(4):749-755. doi: 10.1161/HYPERTENSIONAHA.119.12729. Epub 2019 Aug 13.
Little is known about whether the relationship between hypertension and ischemic stroke differs by sex. We examined sex differences in the association between hypertension severity and treatment and ischemic stroke risk. We used a longitudinal cohort study in the continental United States, with oversampling of black individuals and those living in the stroke belt. We included 26 461 participants recruited from 2003 to 2007 without prevalent stroke at baseline. The main outcome was incident ischemic stroke ascertained by telephone surveillance (with physician adjudication for suspected events). Proportional hazards regression was used to assess the sex-specific association between systolic blood pressure and stroke and between classes of antihypertensive medications and stroke after adjustment for age, race, sex, and age-by-race and sex-by-treatment interaction terms. A priori, <0.10 was considered significant for interactions. Among participants (55.4% women, 40.2% black), there were 1084 confirmed ischemic stroke events. In the adjusted model, the risk of stroke per each level of hypertension (referent/systolic blood pressure <120 mm Hg/120-129 mm Hg/130-139 mm Hg/>140 mm Hg) was higher in women (hazard ratio, 1.25; 95% CI, 1.16-1.34) than men (hazard ratio, 1.14; 95% CI, 1.05-1.23; sex-systolic blood pressure interaction term, =0.09). Compared with no medications, with each additional class of medications, stroke risk increased by 23% (hazard ratio, 1.23; 95% CI, 1.14-1.33) for women and 21% (hazard ratio, 1.21; 95% CI, 1.12-1.31) for men (=0.79). Further work on the biological mechanisms for sex differences in stroke risk associated with hypertension severity and a need for sex-specific clinical guidelines may be warranted.
目前对于高血压与缺血性脑卒中之间的关系是否存在性别差异还知之甚少。本研究旨在探讨高血压严重程度和治疗与缺血性脑卒中风险之间的关联是否存在性别差异。我们采用了美国大陆的一项纵向队列研究,对黑人和处于脑卒中高发带的人群进行了过采样。共纳入了 26461 名参与者,他们在基线时无脑卒中病史,于 2003 年至 2007 年期间通过电话监测(疑似事件由医生裁定)确定有无新发缺血性脑卒中。采用比例风险回归模型评估收缩压和脑卒中之间以及不同类别降压药物与脑卒中之间的性别特异性关联,调整了年龄、种族、性别、年龄与种族以及性别与治疗的交互项。交互项的检验水准为<0.10。在参与者中(55.4%为女性,40.2%为黑人),共确诊了 1084 例缺血性脑卒中事件。在调整模型中,与正常血压(收缩压<120mmHg/120-129mmHg/130-139mmHg/>140mmHg)相比,每升高一个高血压等级(参考值),女性发生脑卒中的风险更高(风险比 1.25;95%可信区间 1.16-1.34),而男性发生脑卒中的风险较低(风险比 1.14;95%可信区间 1.05-1.23;性别与收缩压交互项,P=0.09)。与未服用药物相比,女性每增加一类药物,脑卒中风险增加 23%(风险比 1.23;95%可信区间 1.14-1.33),男性脑卒中风险增加 21%(风险比 1.21;95%可信区间 1.12-1.31;P=0.79)。进一步研究高血压严重程度与脑卒中风险之间的性别差异的生物学机制,并制定针对女性的特异性临床指南可能是必要的。